Growth for Life Science Market Expected to Continue, Wall Street Analyst Says | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Despite the sluggish economy and an overall flat funding picture, the life science market will continue "to provide investors with attractive risk/reward opportunities" over the next several years, with the molecular diagnostics space one of the most attractive markets, according to an analyst report issued last night.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.